CG
UBX

Cutler Group’s Unity Biotechnology UBX Stock Holding History

Cutler Group’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-30
Closed – – 6104
2021
Q3 		$0 Hold
30
– – ﹤0.01% 6390
2021
Q2 		$1K Hold
30
– – ﹤0.01% 5441
2021
Q1 		$1K Sell
30
-690
-96% -$47K ﹤0.01% 5385
2020
Q4 		$37K Buy
720
+530
+279% +$25.6K ﹤0.01% 2225
2020
Q3 		$6K Hold
190
– – ﹤0.01% 3403
2020
Q2 		$16K Buy
190
+20
+12% +$1.48K ﹤0.01% 2557
2020
Q1 		$9K Buy
170
+130
+325% +$8.19K ﹤0.01% 2786
2019
Q4 		$2K Buy
+40
New +$2.82K ﹤0.01% 3518

Other funds holding UBX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Cutler Group's UBX Position: Q4 2021 in Review

Cutler Group sold out of Unity Biotechnology (UBX) in Q4 2021, closing a stake of 30 shares.

Cutler Group first reported a position in UBX in Q4 2019 and held it in 8 quarters. The position peaked at $37K in Q4 2020. 71 funds tracked by Wall St. Rank hold UBX as of Q4 2021.

  • Cutler Group reported no remaining Unity Biotechnology position as of Q4 2021 after selling out during the quarter.
  • Cutler Group sold 30 Unity Biotechnology shares in Q4 2021.
  • Cutler Group first reported a position in Unity Biotechnology in Q4 2019 and held it in 8 quarters.
  • Cutler Group's Unity Biotechnology position peaked at $37K in Q4 2020.
  • 71 funds tracked by Wall St. Rank held Unity Biotechnology as of Q4 2021.

Based on Cutler Group's 13F filing for Q4 2021, filed 18 Jan 2022.